药理学
医学
中医药
糖尿病性心肌病
氧化应激
细胞凋亡
PI3K/AKT/mTOR通路
糖尿病
蛋白激酶B
标记法
脂质代谢
糖酵解
内科学
内分泌学
心肌病
化学
新陈代谢
免疫组织化学
病理
心力衰竭
生物化学
替代医学
作者
Luyang Zhong,Jianhua Li,Jiamin Yu,Xia Cao,Jieyong Du,Lanyuan Liang,Mengru Yang,Yimin Yue,Mantong Zhao,Zhou Tong,Jiazi Lin,Xinghuan Wang,Xuxia Shen,Yanmei Zhong,Yi Wang,Zunpeng Shu
标识
DOI:10.1016/j.jep.2023.117250
摘要
Based on the theory of traditional Chinese medicine (TCM), diabetic cardiomyopathy (DCM) belongs to the category of "Xiaoke disease" according to the symptoms, and "stasis-heat" is the main pathogenesis of DCM. The Chinese medicine Anemarrhena asphodeloides Bunge (AAB), as a representative of heat-clearing and engendering fluid, is often used clinically in the treatment of DCM. Anemarrhena asphodeloides Bunge total saponins (RATS) are the main bioactive components of AAB, the modern pharmacologic effects of RATS are anti-inflammatory, hypoglycemic, and cardioprotective. However, the potential protective mechanisms of RATS against DCM remain largely undiscovered. The primary goal of this study was to explore the effect of RATS on DCM and its mechanism of action. Streptozotocin and a high-fat diet were used to induce DCM in rats. UHPLC/Q-TOF-MS was used to determine the chemical components of RATS. The degenerative alterations and apoptotic cells in the heart were assessed by HE staining and TUNEL. Network pharmacology was used to anticipate the probable targets and important pathways of RATS. The alterations in metabolites and main metabolic pathways in heart tissue were discovered using 1 H-NMR metabolomics. Ultimately, immunohistochemistry was used to find critical pathway protein expression. First of all, UHPLC/Q-TOF-MS analysis showed that RATS contained 11 active ingredients. In animal experiments, we found that RATS lowered blood glucose and lipid levels in DCM rats, and alleviated cardiac pathological damage, and decreased cardiomyocyte apoptosis. Furthermore, the study found that RATS effectively reduced inflammatory factor release and the level of oxidative stress. Mechanistically, RATS downregulated the expression levels of PI3K, AKT, HIF-1α, LDHA, and GLUT4 proteins. Additionally, glycolysis was discovered to be a crucial pathway for RATS in the therapy of DCM. Our findings suggest that the protective effect of RATS on DCM may be attributed to the inhibition of the PI3K/AKT/HIF-1α pathway and the correction of glycolytic metabolism.
科研通智能强力驱动
Strongly Powered by AbleSci AI